The regulation of forebrain dopamine transmission: Relevance to the pathophysiology and psychopathology of schizophrenia

Biological Psychiatry

Volumn 46, Issue 1, 1999, Pages 40-55

  Moore, Holly ^a   West, Anthony R ^a   Grace, Anthony A ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Animal models; Antipsychotic drugs; Dopamine; Glutamate; Nitric oxide; Schizophrenia

Indexed keywords

DOPAMINE; GLUTAMIC ACID; HALOPERIDOL; NITRIC OXIDE;

FOREBRAIN; HUMAN; MENTAL DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; SIGNAL TRANSDUCTION;

BASAL GANGLIA; DOPAMINE; GLUTAMATES; HUMANS; PROSENCEPHALON; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SYNAPTIC TRANSMISSION; TEMPORAL LOBE;

EID: 0032987558     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(99)00078-5     Document Type: Review

References (169)

1. Akbarian S., Bunney W.E. Jr, Potkin S.G., et al. Altered distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development. Arch Gen Psychiatry. 50:1993;169-177.
2. Akbarian S., Vinuela A., Kim J.J., Potkin S.G., Bunney W.E. Jr, Jones E.G. Distorted distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase neurons in temporal lobe of schizophrenics implies anomalous cortical development. Arch Gen Psychiatry. 50:1993;178-187.
3. Amalric M., Koob G.F. Functionally selective neurochemical afferents and efferents of the mesocorticolimbic and nigrostriatal dopamine system. Prog Brain Res. 99:1993;209-226.
4. An X., Lewis D., Sesack S. Ultrastructural localization of dopamine D1 or D2 receptor immunoreactivity in structures postsynaptic to tyrosine hydroxylase-positive terminals in the monkey striatum. Soc Neurosci Abstr. 24:1998;857. (abstract # 340.6).
5. Angrist B.M. Amphtamine psychosis Clinical variations of the syndrome . Cho A.K., Segal D.S. Amphetamine and Its Analogues. 1994;387-414 Academic Press, San Diego, CA.
6. Antonelli T., Govoni B., Bianchi C.L., Beani L. Glutamate regulation of dopamine release in guinea pig striatal slices. Neurochem Int. 30:1997;203-209.
7. Arnold S.E., Trojanowski J.Q. Recent advances in defining the neuropathology of schizophrenia. Acta Neuropathol. 92:1996;217-231.
8. Arnt J., Skarsfeldt T. Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence. Neuropsychopharmacology. 18:1998;63-101.
9. Bachus S.E., Kleinman J.E. The neuropathology of schizophrenia. J Clin Psychiatry. 57:1996;72-83.
10. Baraban S.C., Schwartzkroin P.A. Electrophysiology of CA1 pyramidal neurons in an animal model of neuronal migration disorders Prenatal methylazoxymethanol treatment . Epilepsy Res. 22:1995;145-156.
11. Beninger R.J., Hoffman D.C., Mazurski E.J. Receptor subtype-specific dopaminergic agents and conditioned behavior. Neurosci Biobehav Rev. 13:1989;113-122.
12. Bergquist F., Jonason J., Pileblad E., Nissbrandt H. Effects of local administration of L-, N- and P/Q-type calcium channel blockers on spontaneous dopamine release in the striatum and the substantia nigra A microdialysis study in rat . J Neurochem. 70:1998;1532-1540.
13. Bevan M.D., Francis C.M., Bolam J.P. The glutamate-enriched cortical and thalamic input to neurons in the subthalamic nucleus of the rat Convergence with GABA-positive terminals . J Comp Neurol. 361:1995;491-511.
14. Blaha C.D., Yang C.R., Floresco S.B., Barr A.M., Phillips A.G. Stimulation of the ventral subiculum of the hippocampus evokes glutamate receptor-mediated changes in dopamine efflux in the rat nucleus accumbens. Eur J Neurosci. 9:1997;902-911.
15. Bouyer J.J., Park D.H., Joh T.H., Pickel V.M. Chemical and structural analysis of the relation between cortical inputs and tyrosine hydroxylase-containing terminals in rat neostriatum. Brain Res. 302:1984;267-275.
16. Breier A., Adler C.M., Weisenfeld N., et al. Effects of NMDA antagonism on striatal dopamine release in healthy subjects application of a novel PET approach . Synapse. 29:1998;142-147.
17. Breier A., Malhotra A.K., Pinals D.A., Weisenfeld N.I., Pickar D. Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers. Am J Psychiatry. 154:1997;805-811.
18. Breier A., Su T.P., Saunders R., et al. Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations Evidence from a novel positron emission tomography method . Proc Natl Acad Sci U S A. 94:1997;2569-2574.
19. Calabresi P., Pisani A., Centonze D., Bernardi G. Synaptic plasticity and physiological interactions between dopamine and glutamate in the striatum. Neurosci Biobehav Rev. 21:1997;519-523.
20. Carpenter W.T. Jr, Buchanan R.W. Schizophrenia. N Engl J Med. 330:1994;681-690.
21. Carter C.J., Heureux R.L., Scatton B. Differential control by N-methyl-D-aspartate and kainate of striatal dopamine release in vivo A trans-striatal dialysis study . J Neurochem. 51:1988;462-468.
22. Carter C.S., Barch D.M. Attention, memory and language disturbances in schizophrenia Clinical and Pathophysiological implications . Andrade C. Advances in Psychiatry. 1999;Oxford University Press, in press, London/New Delhi.
23. Cattabeni F., Di Luca M. Developmental models of brain dysfunctions induced by targeted cellular ablations with methylazoxymethanol. Physiol Rev. 77:1997;199-215.
24. Cepeda C., Colwell C.S., Itri J.N., Chandler S.H., Levine M.S. Dopaminergic modulation of NMDA-induced whole cell currents in neostriatal neurons in slices Contribution of calcium conductances . J Neurophysiol. 79:1998;82-94.
25. Cepeda C., Levine M.S. Dopamine and N-methyl-D-aspartate receptor interactions in the neostriatum. Dev Neurosci. 20:1998;1-18.
26. Cheramy A., Barbeito L., Godeheu G., et al. Respective contributions of neuronal activity and presynaptic mechanisms in the control of the in vivo release of dopamine. J Neural Transm Suppl. 29:1990;183-193.
27. Chesselet M.F. Presynaptic regulation of dopamine release. Implications for the functional organization of the basal ganglia. Ann N Y Acad Sci. 604:1990;17-22.
28. Christie B.R., Eliot L.S., Ito K., Miyakawa H., Johnston D. Different Ca2+ channels in soma and dendrites of hippocampal pyramidal neurons mediate spike-induced Ca2+ influx. J Neurophysiol. 73:1995;2553-2557.
29. Dao-Castellana M.H., Paillere-Martinot M.L., Hantraye P., et al. Presynaptic dopaminergic function in the striatum of schizophrenic patients. Schizophr Res. 23:1997;167-174.
30. 2 receptor within GABAergic neurons of the rat striatum. Brain Res. 746:1997;239-255.
31. Descarries L., Watkins K.C., Garcia S., Bosler O., Doucet G. Dual character, asynaptic and synaptic, of the dopamine innervation in adult rat neostriatum A quantitative autoradiographic and immunocytochemical analysis . J Comp Neurol. 375:1996;167-186.
32. Desce J.M., Godeheu G., Galli T., Artaud F., Cheramy A., J Glowinski J. L-glutamate-evoked release of dopamine from synaptosomes of the rat striatum Involvement of AMPA and N-methyl-D-aspartate receptor . Neuroscience. 47:1992;333-339.
33. Ettenberg A. Dopamine, neuroleptics and reinforced behavior. Neurosci Biobehav Rev. 13:1989;105-111.
34. Everitt B.J., Cador M., Robbins T.W. Interactions between the amygdala and ventral striatum in stimulus-reward associations Studies using a second-order schedule of sexual reinforcement . Neuroscience. 30:1989;63-75.
35. Finlay J.M., Zigmond M.J. The effects of stress on central dopaminergic neurons Possible clinical implications . Neurochem Res. 22:1997;1387-1394.
36. Fischer M., Kaech S., Knutti D., Matus A. Rapid actin-based plasticity in dendritic spines. Neuron. 20:1998;847-854.
37. Floresco S.B., Yang C.R., Phillips A.G., Blaha C.D. Basolateral amygdala stimulation evokes glutamate receptor-dependent dopamine efflux in the nucleus accumbens of the anaesthetized rat. Eur J Neurosci. 10:1998;1241-1251.
38. Flores-Hernandez J., Galarraga E., Bargas J. Dopamine selects glutamatergic inputs to neostriatal neurons. Synapse. 25:1997;185-195.
39. Freund T.F., Smith A.D. Tyrosine hydroxylase-immunoreactive boutons in synaptic contact with identified striatonigral neurons, with particular reference to dendritic spines. Neuroscience. 13:1984;1189-1215.
40. Frith C. Neuropsychology of schizophrenia, what are the implications of intellectual and experimental abnormalities for the neurobiology of schizophrenia? Br Med Bull. 52:1996;618-626.
41. Fujiyama F., Masuko S. Association of dopaminergic terminals and neurons releasing nitric oxide in the rat striatum an electron microscopic study using NADPH-diaphorase histochemistry and tyrosine hydroxylase immunohistochemistry . Brain Res Bull. 40:1996;121-127.
42. Garris P.A., Christensen J.R., Rebec G.V., Wightman R.M. Real-time measurement of electrically evoked extracellular dopamine in the striatum of freely moving rats. J Neurochem. 68:1997;152-161.
43. Garris P.A., Ciolkowski E.L., Pastore P., Wightman R.M. Efflux of dopamine from the synaptic cleft in the nucleus accumbens of the rat brain. J Neurosci. 14:1994;6084-6093.
44. Garris P.A., Wightman R.M. Different kinetics govern dopaminergic transmission in the amygdala, prefrontal cortex, and striatum An in vivo voltammetric study . J Neurosci. 14:1994;442-450.
45. Garthwaite J., Charles S.J., Chess-Williams R. Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature. 336:1988;385-388.
46. Ghajarnia M., Moore H., Grace A.A. Enhanced behavioral effects of phencyclidine in rats with developmental abnormalities of the temporal lobe. Soc Neurosci Abstr. 24:1998;2177.
47. Goldman-Rakic P.S. Regional and cellular fractionation of working memory. Proc Natl Acad Sci U S A. 93:1996;13473-13480.
48. Goldman-Rakic P.S., Lidow M.S., Smiley J.F., Williams M.S. The anatomy of dopamine in monkey and human prefrontal cortex. J Neural Transm Suppl. 36:1992;163-177.
49. Grace A.A. Phasic versus tonic dopamine release and the modulation of dopamine system responsivity A hypothesis for the etiology of schizophrenia . Neuroscience. 41:1991;1-24.
50. Grace AA (1993): Cortical regulation of subcortical dopamine systems and its possible relevance to schizophrenia. J Neural Transm, General Section 91:111-134.
51. Grace A.A., Bunney B.S. The control of firing pattern in nigral dopamine neurons Burst firing . J Neurosci. 4:1984;2877-2890.
52. Grace A.A., Bunney B.S. Opposing effects of striatonigral feedback pathways on midbrain dopamine cell activity. Brain Res. 333:1985;271-284.
53. Grace A.A., Bunney B.S., Moore H., Todd C.L. Dopamine-cell depolarization block as a model for the therapeutic actions of antipsychotic drugs. Trends Neurosci. 20:1997;31-37.
54. Grace A.A., Moore H. Regulation of information flow in the nucleus accumbens A model for the pathophysiology of schizophrenia . Lenzenweger M.F., Sworkin R.H. Origins and Development of Schizophrenia Advances in Experimental Psychopathology . 1998;123-160 APA, Washington DC.
55. Gracy K.N., Pickel V.M. Ultrastructural immunocytochemical localization of the N-methyl-D-aspartate receptor and tyrosine hydroxylase in the shell of the rat nucleus accumbens. Brain Res. 739:1996;169-181.
56. Gracy K.N., Pickel V.M. Ultrastructural localization and comparative distribution of nitric oxide synthase and N-methyl-D-aspartate receptors in the shell of the rat nucleus accumbens. Brain Res. 747:1997;259-272.
57. Gray J.A. Dopamine release in the nucleus accumbens The perspective from aberrations of consciousness in schizophrenia . Neuropsychologia. 33:1995;1143-1153.
58. Greif G.J., Lin Y.J., Liu J.C., Freedman J.E. Dopamine-modulated potassium channels on rat striatal neurons Specific activation and cellular expression . J Neurosci. 15:1995;4533-4544.
59. Gresch P.J., Sved A.F., Zigmond M.J., Finlay J.M. Local influence of endogenous norepinephrine on extracellular dopamine in rat medial prefrontal cortex. J Neurochem. 65:1995;111-116.
60. Groenewegen H.J., Wright C.I., Beijer A.V. The nucleus accumbens Gateway for limbic structures to reach the motor system? Prog Brain Res. 107:1996;485-511.
61. Groves P.M., Linder J.C., Young S.J. 5-hydroxydopamine-labeled dopaminergic axons Three-dimensional reconstructions of axons, synapses and postsynaptic targets in rat neostriatum . Neuroscience. 58:1994;593-604.
62. Gulledge A.T., Jaffe D.B. Dopamine decreases the excitability of layer V pyramidal cells in the rat prefrontal cortex. J Neurosci. 18:1998;9139-9151.
63. Haber S.N., Fudge J.L. The primate substantia nigra and VTA Integrative circuitry and function . Crit Rev Neurobiol. 11:1997;323-342.
64. Hanbauer I., Wink D., Osawa Y., Edelman G.M. Role of nitric oxide in NMDA-evoked release of [3H]-dopamine from striatal slices. Neuroreport. 3:1992;409-412.
65. Heresco-Levy U., Javitt D.C. The role of N-methyl-D-aspartate (NMDA) receptor-mediated neurotransmission in the pathophysiology and therapeutics of psychiatric syndromes. Eur Neuropsychopharmacology. 8:1998;141-152.
66. Hernandez-Lopez S., Bargas J., Surmeier D.J., Reyes A., Galarraga E. D1 receptor activation enhances evoked discharge in neostriatal medium spiny neurons by modulating an L-type Ca2+ conductance. J Neurosci. 17:1997;3334-3342.
67. Hersch S.M., Ciliax B.J., Gutekunst C.-A., et al. Electron microscopic analysis of D1 and D2 receptor proteins in the dorsal striatum and their synaptic relationships with motor corticostriatal afferents. J Neurosci. 15:1995;5222-5237.
68. Horvitz J.C., Stewart T., Jacobs B.L. Burst activity of ventral tegmental dopamine neurons is elicited by sensory stimuli in the awake cat. Brain Res. 759:1997;251-258.
69. Hsu K.S. Characterization of dopamine receptors mediating inhibition of excitatory synaptic transmission in the rat hippocampal slice. J Neurophysiol. 76:1996;1887-1895.
70. Imperato A., Scrocco M.G., Bacchi S., Angelucci L. NMDA receptors and in vivo dopamine release in the nucleus accumbens and caudatus. Eur J Pharmacol. 187:1990;555-556.
71. Iravani M.M., Kruk Z.L. Real-time effects of N-methyl-D-aspartic acid on dopamine release in slices of rat caudate putamen A study using fast cyclic voltammetry . J Neurochem. 66:1996;1076-1085.
72. Jentsch J.D., Roth R.H. The neuropsychopharmacology of phencyclidine From NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia . Neuropsychopharmacology. 20:1999;201-225.
73. Jin S., Fredholm B.B. Role of NMDA, AMPA and kainate receptors in mediating glutamate and 4-AP-induced dopamine and acetylcholine release from rat striatal slices. Neuropharmacology. 33:1994;1039-1048.
74. Keefe K.A., Zigmond M.J., Abercrombie E.D. Extracellular DA in striatum Influence of nerve impulse activity in medial forebrain bundle and local glutamatergic input . Neuroscience. 47:1992;325-332.
75. Krebs M.O., Desce J.M., Kemel M.L., et al. Glutamatergic control of dopaminergic release in the rat striatum evidence for presynaptic N-methyl-D-aspartate receptors on dopaminergic terminals . J Neurochem. 56:1991;81-85.
76. Kuczenski R., Segal D.S. Neurochemistry of amphetamine. Cho A.K., Segal D.S. Amphetamine and Its Analogs. 1994;81-114 Academic Press, San Diego, CA.
77. Laruelle M., Abi-Dargham A., van Dyck C.H., et al. Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proc Natl Acad Sci U S A. 93:1996;9235-9240.
78. Laruelle M., D'Souza C.D., Baldwin R.M., et al. Imaging D2 receptor occupancy by endogenous dopamine in humans. Neuropsychopharmacology. 17:1997;162-174.
79. Laruelle M., Iyer R.N., al-Tikriti M.S., et al. Microdialysis and SPECT measurements of amphetamine-induced dopamine release in nonhuman primates. Synapse. 25:1997;1-14.
80. Ledoux J.E., Muller J. Emotional memory and psychopathology. Philos Trans R Soc Lond B Biol Sci. 352:1997;1719-1726.
81. Li X.M., Perry K.W., Wong D.T., Bymaster F.P. Olanzapine increases in vivo dopamine and norepinephrine release in rat prefrontal cortex, nucleus accumbens and striatum. Psychopharmacology. 136:1998;153-161.
82. Liddle P.F., Barnes T.R., Speller J., Kibel D. Negative symptoms as a risk factor for tardive dyskinesia in schizophrenia. Br J Psychiatry. 163:1993;776-780.
83. Liddle P.F., Friston K.J., Frith C.D., Frackowiak R.S. Cerebral blood flow and mental processes in schizophrenia. J R Soc Med. 85:1992;224-227.
84. Lin A.M.Y., Kao L.S., Chai C.Y. Involvement of nitric oxide in dopaminergic transmission in rat striatum An in vivo electrochemical study . J Neurochem. 65:1995;2043-2049.
85. Lipska B.K., Swerdlow N.R., Geyer M.A., Jaskiw G.E., Braff D.L., Weinberger D.R. Neonatal excitotoxic hippocampal damage in rats causes post-pubertal changes in prepulse inhibition of startle and its disruption by apomorphine. Psychopharmacology. 122:1995;35-43.
86. Maeda H., Mogenson G.J. Electrophysiological responses of neurons of the ventral tegmental area to electrical stimulation of amygdala and lateral septum. Neuroscience. 6:1981;367-376.
87. Meltzer H.Y. An overview of the mechanism of action of clozapine. J Clin Psychiatry. 55:(suppl B):1994;47-52.
88. Meltzer H.Y., Kennedy J., Dai J., Parsa M., Riley D. Plasma clozapine levels and the treatment of L-DOPA-induced psychosis in Parkinson's disease. A high potency effect of clozapine. Neuropsychopharmacology. 12:1995;39-45.
89. Miller R. Striatal dopamine in reward and attention A system for understanding the symptomatology of acute schizophrenia and mania . Int Rev Neurobiol. 35:1993;161-178.
90. Moghaddam B., Adams B.W. Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats. Science. 281:1998;1349-1352.
91. Moghaddam B., Bolinao M.L. Glutamatergic antagonists attenuate ability of dopamine uptake blockers to increase extracellular levels of dopamine Implications for tonic influence of glutamate on dopamine release . Synapse. 18:1994;337-342.
92. Moghaddam B., Gruen R. Do endogenous excitatory amino acids influence striatal DA release? Brain Res. 544:1991;329-330.
93. Moore H, Grace AA (1997): Anatomical changes in limbic structures produced by methylazoxymethanol acetate (MAM) during brain development are associated with changes in physiological interactions among afferents to the nucleus accumbens. Soc Neurosci Abstr 23:2378, Abstract 926.8.
94. Moore H., Todd C.L., Grace A.A. Striatal extracellular dopamine levels in rats with haloperidol-induced depolarization block of substantia nigra dopamine neurons. J Neurosci. 18:1998;5068-5077.
95. Morari M., O'Connor W.T., Darvelid M., Ungerstedt U., Bianchi C., Fuxe K. Functional neuroanatomy of the nigrostriatal and striatonigral pathways as studied with dual probe microdialysis in the awake rat - I. Effects of perfusion with tetrodotoxin and low-calcium medium. Neuroscience. 72:1996;79-87.
96. Morari M., O'Connor W.T., Ungerstedt U., Fuxe K. N-methyl-D-aspartic acid differentially regulates extracellular dopamine, GABA, and glutamate levels in the dorsolateral neostriatum of the halothane-anesthetized rat An in vivo microdialysis study . J Neurochem. 60:1993;1884-1893.
97. Murase S., Grenoff J., Chouvet G., Gonon F.G., Svennson T. Prefrontal cortex regulates burst firing and transmitter release in rat mesolimbic dopamine neurons studied in vivo. Neurosci Letts. 157:1993;53-56.
98. Nakajima S. Subtypes of dopamine receptors involved in the mechanism of reinforcement. Neurosci Biobehav Rev. 13:1989;123-128.
99. Nisenbaum E.S., Wilson C.J. Potassium currents responsible for inward and outward rectification in rat neostriatal spiny projection neurons. J Neurosci. 15:1995;4449-4463.
100. O'Donnell P (1998): Ensemble coding in the nucleus accumbens. Psychobiology, in press.
101. O'Donnell P., Grace A.A. Tonic D2-mediated attenuation of cortical excitation in nucleus accumbens neurons recorded in vitro. Brain Res. 634:1994;105-112.
102. O'Donnell P., Grace A.A. Synaptic interactions among excitatory afferents to nucleus accumbens neurons Hippocampal gating of prefrontal cortical input . J Neurosci. 15:1995;3622-3639.
103. O'Donnell P., Grace A.A. Cortical afferents modulate striatal gap junction permeability via nitric oxide. Neuroscience. 76:1997;1-5.
104. O'Donnell P., Grace A.A. Dysfunctions in multiple interrelated systems as the neurobiological bases of schizophrenic symptom clusters. Schizophr Bull. 24:1998;267-283.
105. Oei T.P., King M.G. Catecholamines and aversive learning a review . Neurosci Biobehav Rev. 4:1980;161-173.
106. Ohno M., Watanabe S. Persistent increase in dopamine release following activation of metabotropic glutamate receptors in the rat nucleus accumbens. Neurosci Letts. 200:1995;113-116.
107. Otani S., Blond O., Desce J.M., Crepel F. Dopamine facilitates long-term depression of glutamatergic transmission in rat prefrontal cortex. Neuroscience. 85:1998;669-676.
108. Otmakhova N.A., Lisman J.E. D1/D5 dopamine receptor activation increases the magnitude of early long-term potentiation at CA1 hippocampal synapses. J Neurosci. 16:1996;7478-7486.
109. Overton P.G., Clark D. Burst firing in midbrain dopaminergic neurons. Brain Res Rev. 25:1997;312-334.
110. Pare D., Lebel E., Lang E.J. Differential impact of miniature synaptic potentials on the soma and dendrites of pyramidal neurons in vivo. J Neurophysiol. 78:1997;1735-1739.
111. Parsons L.H., Justice J.B. Jr. Extracellular concentration and in vivo recovery of dopamine in the nucleus accumbens using microdialysis. J Neurochem. 58:1992;212-218.
112. Ponce A., Bueno E., Kentros C., et al. G-protein-gated inward rectifier K+ channel proteins (GIRK1) are present in the soma and dendrites as well as in nerve terminals of specific neurons in the brain. J Neurosci. 16:1996;1990-2001.
113. Pothos E.N., Davila V., Sulzer D. Presynaptic recording of quanta from midbrain dopamine neurons and modulation of the quantal size. J Neurosci. 18:1998;4106-4118.
114. Pucak M.L., Grace A.A. Regulation of substantia nigra dopamine neurons. Crit Rev Neurobiol. 9:1994;67-89.
115. Robbins T.W., Cador M., Taylor J.R., Everitt B.J. Limbic-striatal interactions in reward-related processes. Neurosci Biobehav Rev. 13:1989;155-162.
116. Robinson T.E., Camp D.M. Does amphetamine preferentially increase the extracellular concentration of dopamine in the mesolimbic system of freely moving rats? Neuropsychopharmacology. 3:1990;163-173.
117. Robinson T.E., Whishaw I.Q. Normalization of extracellular dopamine in striatum following recovery of a partial unilateral 6-OHDA lesion of the substantia nigra A microdialysis study in freely moving rats . Brain Res. 450:1988;209-224.
118. Rogers R.D., Sahakian B.J., Hodges J.R., Polkey C.E., Kennard C., Robbins T.W. Dissociating executive mechanisms of task control following frontal lobe damage and Parkinson's disease. Brain. 121:(pt 5):1998;815-842.
119. Rouillard C., Freeman A.S. Effects of electrical stimulation of the central nucleus of the amygdala on the in vivo electrophysiological activity of rat nigral dopaminergic neurons. Synapse. 21:1995;348-356.
120. Sacaan A.L., Bymaster F.P., Schoepp D.D. Metabotropic glutamate receptor activation produces extrapyramidal motor system activation that is mediated by striatal dopamine. J Neurochem. 59:1992;245-251.
121. Sakai K., Akiyama K., Kashihara K., et al. AMPA receptors modulate dopamine release in the striatum, as measured by brain microdialysis. Neurochem Intl. 30:1997;329-336.
122. Salamone J.D. The involvement of nucleus accumbens dopamine in appetitive and aversive motivation. Behav Brain Res. 61:1994;117-133.
123. Saulskaya N., Marsden C.A. Conditioned dopamine release Dependence upon N-methyl-D-aspartate receptors . Neuroscience. 67:1995;57-63.
124. Saulskaya N., Marsden C.A. Extracellular glutamate in the nucleus accumbens during a conditioned emotional response in the rat. Brain Res. 698:1995;114-120.
125. Schultz W. Predictive reward signal of dopamine neurons. J Neurophysiol. 80:1998;1-27.
126. Seeman P. Dopamine receptors and the dopamine hypothesis of schizophrenia. Synapse. 1:1987;133-152.
127. Sedvall G., Pauli S., Karlsson P., et al. PET imaging of neuroreceptors in schizophrenia. Eur Neuropsychopharmacol. 5:(suppl 1):1995;25-30.
128. Segovia G., Del Arco A., Mora F. Endogenous glutamate increases extracellular concentrations of dopamine, GABA, and taurine through NMDA and AMPA/kainate receptors in striatum of the freely moving rat a microdialysis study . J Neurochem. 69:1997;1476-1483.
129. Sesack S.R., Hawrylak V.A., Matus C., Guido M.A., Levey A.I. Dopamine axon varicosities in the prelimbic division of the rat prefrontal cortex exhibit sparse immunoreactivity for the dopamine transporter. J Neurosci. 18:1998;2697-2708.
130. Sesack S.R., Pickel V.M. In the rat medial nucleus accumbens, hippocampal and catecholaminergic terminals converge on spiny neurons and are in apposition to each other. Brain Res. 527:1990;266-279.
131. Shibata M., Araki N., Ohta K., Hamada J., Shimazu K., Fukuuchi Y. Nitric oxide regulates NMDA-induced dopamine release in rat striatum. Neuroreport. 7:1996;605-608.
132. Silva A., Giese K.P., Fedorov N.B., Frankland P.W., Kogan J.H. Molecular, cellular, and neuroanatomical substrates of place learning. Neurobiol Learn Mem. 70:1998;44-61.
133. Smith I.D., Grace A.A. Role of the subthalamic nucleus in the regulation of nigral dopamine neuron activity. Synapse. 12:1992;287-303.
134. Smolders I., Sarre C., Vanhaesendonck C., Ebinger G., Michotte Y. Extracellular striatal dopamine and glutamate after decortication and kainate receptor stimulation, as measured by microdialysis. J Neuroschem. 66:1996;2373-2380.
135. Snyder S.H. The dopamine hypothesis of schizophrenia Focus on the dopamine receptor . Am J Psychiatry. 133:1976;197-202.
136. Stern E.A., Kincaid A.E., Wilson C.J. Spontaneous subthreshold membrane potential fluctuations and action potential variability of rat corticostriatal and striatal neurons in vivo. J Neurophysiol. 77:1997;1697-1715.
137. Surmeier D.J., Kitai S.T. State-dependent regulation of neuronal excitability by dopamine. Nihon Shinkei Seishin Yakurigaku Zasshi. 17:1997;105-110.
138. Surmeier D.J., Kitai S.T. D1 and D2 modulation of sodium and potassium currents in rat neostriatal neurons. Prog Brain Res. 99:1993;309-324.
139. Swerdlow N.R., Geyer M.A. Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia. Schizophr Bull. 24:1998;285-301.
140. Taber M.T., Das S., Fibiger H.C. Cortical regulation of subcortical dopamine release Mediation via the ventral tegmental area . J Neurochem. 65:1995;1407-1410.
141. Tamminga C.A., Dale J.M., Goodman L., Kaneda H., Kaneda N. Neuroleptic-induced vacuous chewing movements as an animal model of tardive dyskinesia A study in three rat strains . Psychopharmacology. 102:1990;474-478.
142. Tamminga C.A., Thaker G.K., Buchanan R., et al. Limbic system abnormalities identified in schizophrenia using positron emission tomography with fluorodeoxyglucose and neocortical alterations with deficit syndrome. Arch Gen Psychiatry. 49:1992;522-530.
143. Tarazi F.I., Campbell A., Yeghiatan S.K., Baldessarini R.J. Localization of ionotropic glutamate receptors in caudate-putamen and nucleus accumbens septi of rat brain Comparison of NMDA, AMPA, and kainate receptors . Synapse. 30:1998;227-235.
144. Todd C.L., Grace A.A. Modulation of ventral tegmental area dopamine cell activity by the ventral subiculum. Soc Neurosci Abstr. 24:1998;1642.
145. Verhage M., Ghijsen W.E., Boomsma F., Lopes da Silva F.H. Endogenous noradrenaline and dopamine in nerve terminals of the hippocampus Differences in levels and release kinetics . J Neurochem. 59:1992;881-887.
146. Verma A., Moghaddam B. Regulation of striatal dopamine release by metabotropic glutamate receptors. Synapse. 28:1998;220-226.
147. Voorn P., Jorritsma-Byham B., Van Dijk C., Buijs R.M. The dopaminergic innervation of the ventral striatum in the rat a light- and electron-microscopical study with antibodies against dopamine . J Comp Neurol. 251:1986;84-99.
148. Vuillet J., Kerkerian L., Kachidian P., Bosler O., Nieoullon A. Ultrastructural correlates of functional relationships between nigral dopaminergic or cortical afferent fibers and neuropeptide Y-containing neurons in the rat striatum. Neurosci Letts. 100:1989;99-104.
149. Waddington J.L. Spontaneous orofacial movements induced in rodents by very long-term neuroleptic drug administration Phenomenology, pathophysiology and putative relationship to tardive dyskinesia . Psychopharmacology. 101:1990;431-447.
150. Watanabe M., Shimizu K., Kodama Y., Takishima K., Mamiya G., Ichinowatari N. Potentiating effects of methamphetamine on the hyperactivity of microencephalic rats treated prenatally with methylazoxymethanol possible implication of hyperdopaminergia . Brain Res. 670:1995;173-180.
151. Weinberger D.R., Berman K.F. Prefrontal function in schizophrenia confounds and controversies . Philos Trans R Soc Lond B Biol Sci. 351:1996;1495-1503.
152. Weinberger D.R., Lipska B.K. Cortical maldevelopment, anti-psychotic drugs, and schizophrenia a search for common ground . Schizophr Res. 16:1995;87-110.
153. West A.R., Galloway M.P. Endogenous nitric oxide facilitates striatal dopamine and glutamate efflux in vivo Role of ionotropic glutamate receptor-dependent mechanisms . Neuropharmacology. 36:1997;1571-1581.
154. West A.R., Galloway M.P. Inhibition of glutamate reuptake potentiates endogenous nitric oxide facilitated dopamine efflux in the rat striatum An in vivo microdialysis study . Neurosci Letts. 230:1997;21-24.
155. West A.R., Galloway M.P. Intrastriatal infusion of (±)-S-nitroso-N-acetylpenicillamine releases vesicular dopamine via an ionotropic glutamate receptor-mediated mechanism An in vivo microdialysis study in chloral hydrate-anesthetized rats . J Neurochem. 66:1996;1971-1980.
156. West A.R., Grace A.A. Role of striatal nitric oxide signaling in the cortical and striatal regulation of midbrain dopamine neuronal activity. Soc Neurosci Abstr. 24:1998;350.
157. Westerink B.H.C., Santiago M., Vries J.B.D. The release of dopamine from nerve terminals and dendrites of nigrostriatal neurons induced by excitatory amino acids in the conscious rat. Naunyn Scmiedebergs Arch Pharmacol. 345:1992;523-529.
158. Wheeler D., Boutelle M.G., Fillenz M. The role of N-methyl-D-aspartate receptors in the regulation of physiologically released dopamine. Neuroscience. 65:1995;767-774.
159. White F.J. Synaptic regulation of mesocortical dopamine neurons. Ann Rev Neurosci. 19:1996;405-436.
160. Wickens J.R., Begg A.J., Arbuthnott G.W. Dopamine reverses the depression of rat corticostriatal synapses which normally follows high-frequency stimulation of cortex in vitro. Neuroscience. 70:1996;1-5.
161. Wiley J.L. Nitric oxide synthase inhibitors attenuate phencyclidine-induced disruption of prepulse inhibition. Neuropsychopharmacology. 19:1998;86-94.
162. Wilson C.J. Dynamic modification of dendritic cable properties and synaptic transmission by voltage-gated potassium channels. J Comp Neurosci. 2:1995;91-115.
163. Wilson C.J., Kawaguchi Y. The origins of two-state spontaneous membrane potential fluctuations of neostriatal spiny neurons. J Neurosci. 16:1996;2397-2410.
164. Yamamoto B., Novotney S. Regulation of extracellular dopamine by the norepinephrine transporter. J Neurochem. 71:1998;274-280.
165. Yamamoto B.K., Pehek E.A., Meltzer H.Y. Brain region effects of clozapine on amino acid and monoamine transmission. J Clin Psychiatry. 55:(suppl B):1994;8-14.
166. Yang C.R., Mogenson G.J. Electrophysiological responses of neurons in the accumbens nucleus to hippocampal stimulation and the attenuation of the excitatory responses by the mesolimbic dopaminergic system. Brain Res. 324:1984;69-84.
167. Yang C.R., Seamans J.K. Dopamine D1 receptor actions in layers V-VI rat prefrontal cortex neurons in vitro modulation of dendritic-somatic signal integration . J Neurosci. 16:1996;1922-1935.
168. Yung K.K., Bolam J.P., Smith A.D., Hersch S.M., Ciliax B.J., Levey A.I. Immunocytochemical localization of D1 and D2 dopamine receptors in the basal ganglia of the rat Light and electron microscopy . Neuroscience. 65:1995;709-730.
169. Zigmond M.J., Abercrombie E.D., Berger T.W., Grace A.A., Stricker E.M. Compensations after lesions of central dopaminergic neurons some clinical and basic implications . Trends Neurosci. 13:1990;290-296.